{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T21:55:53Z","timestamp":1766267753702},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1038\/s41390-022-02133-5","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T13:04:00Z","timestamp":1654779840000},"page":"661-665","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impacts of exposure to topical calcineurin inhibitors on metabolism in vitiligo infants"],"prefix":"10.1038","volume":"93","author":[{"given":"Wenting","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuquan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiehao","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai\u2011e","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"2133_CR1","first-page":"1","volume":"24","author":"AF Nahhas","year":"2019","unstructured":"Nahhas, A. F., Braunberger, T. L. & Hamzavi, I. H. Update on the management of vitiligo. Ski. Ther. Lett. 24, 1\u20136 (2019).","journal-title":"Ski. Ther. Lett."},{"key":"2133_CR2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMcp0804388","volume":"360","author":"A Taieb","year":"2009","unstructured":"Taieb, A. & Picardo, M. Clinical practice. Vitiligo. N. Engl. J. Med. 360, 160\u2013169 (2009).","journal-title":"N. Engl. J. Med."},{"key":"2133_CR3","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1001\/jama.293.6.730","volume":"293","author":"PE Grimes","year":"2005","unstructured":"Grimes, P. E. New insights and new therapies in vitiligo. JAMA 293, 730\u2013735 (2005).","journal-title":"JAMA"},{"key":"2133_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4049\/jimmunol.1900027","volume":"203","author":"RL Riding","year":"2019","unstructured":"Riding, R. L. & Harris, J. E. The role of memory CD8(+) T cells in vitiligo. J. Immunol. 203, 11\u201319 (2019).","journal-title":"J. Immunol."},{"key":"2133_CR5","doi-asserted-by":"crossref","unstructured":"Fraczek, A., Owczarczyk-Saczonek, A. & Placek, W. The role of TRM cells in the pathogenesis of vitiligo-a review of the current state-of-the-art. Int. J. Mol. Sci. 21, 3552 (2020).","DOI":"10.3390\/ijms21103552"},{"key":"2133_CR6","doi-asserted-by":"crossref","unstructured":"Wu, J., Zhou, M., Wan, Y. & Xu, A. CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis. Mol. Med. Rep. 7, 237\u2013241 (2013).","DOI":"10.3892\/mmr.2012.1117"},{"key":"2133_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.autrev.2006.03.012","volume":"5","author":"K Oyarbide-Valencia","year":"2006","unstructured":"Oyarbide-Valencia, K. et al. Therapeutic implications of autoimmune vitiligo T cells. Autoimmun. Rev. 5, 486\u2013492 (2006).","journal-title":"Autoimmun. Rev."},{"key":"2133_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1078\/0171-9335-00423","volume":"83","author":"J Steitz","year":"2004","unstructured":"Steitz, J., Wenzel, J., Gaffal, E. & Tuting, T. Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo. Eur. J. Cell Biol. 83, 797\u2013803 (2004).","journal-title":"Eur. J. Cell Biol."},{"key":"2133_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","volume":"83","author":"A Wankowicz-Kalinska","year":"2003","unstructured":"Wankowicz-Kalinska, A. et al. Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Lab. Invest. 83, 683\u2013695 (2003).","journal-title":"Lab. Invest."},{"key":"2133_CR10","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","volume":"159","author":"DJ Gawkrodger","year":"2008","unstructured":"Gawkrodger, D. J. et al. Guideline for the diagnosis and management of vitiligo. Br. J. Dermatol. 159, 1051\u20131076 (2008).","journal-title":"Br. J. Dermatol."},{"key":"2133_CR11","doi-asserted-by":"crossref","unstructured":"Lee, J. H. et al. Treatment outcomes of topical calcineurin inhibitor therapy for patients with vitiligo: a systematic review and meta-analysis. JAMA Dermatol. 155, 929\u2013938 (2019).","DOI":"10.1001\/jamadermatol.2019.0696"},{"key":"2133_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jaad.2019.07.108","volume":"82","author":"HC Chang","year":"2020","unstructured":"Chang, H. C., Hsu, Y. P. & Huang, Y. C. The effectiveness of topical calcineurin inhibitors compared with topical corticosteroids in the treatment of vitiligo: a systematic review and meta-analysis. J. Am. Acad. Dermatol. 82, 243\u2013245 (2020).","journal-title":"J. Am. Acad. Dermatol."},{"key":"2133_CR13","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s40257-019-00430-0","volume":"20","author":"E Nicolaidou","year":"2019","unstructured":"Nicolaidou, E., Mastraftsi, S., Tzanetakou, V. & Rigopoulos, D. Childhood vitiligo. Am. J. Clin. Dermatol. 20, 515\u2013526 (2019).","journal-title":"Am. J. Clin. Dermatol."},{"key":"2133_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41584-020-0374-8","volume":"16","author":"JCA Broen","year":"2020","unstructured":"Broen, J. C. A. & van Laar, J. M. Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology. Nat. Rev. Rheumatol. 16, 167\u2013178 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"2133_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CCID.S3378","volume":"2","author":"A Baldo","year":"2009","unstructured":"Baldo, A., Cafiero, M., Di, C. P. & Di, C. L. Tacrolimus ointment in the management of atopic dermatitis. Clin. Cosmet. Investig. Dermatol. 2, 1\u20137 (2009).","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"2133_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1463-5224.2005.00390.x","volume":"8","author":"A Berdoulay","year":"2005","unstructured":"Berdoulay, A., English, R. V. & Nadelstein, B. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca. Vet. Ophthalmol. 8, 225\u2013232 (2005).","journal-title":"Vet. Ophthalmol."},{"key":"2133_CR17","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","volume":"66","author":"J Liu","year":"1991","unstructured":"Liu, J. et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807\u2013815 (1991).","journal-title":"Cell"},{"key":"2133_CR18","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.3760\/cma.j.issn.0366-6999.20140314","volume":"127","author":"H Huang","year":"2014","unstructured":"Huang, H. et al. Effect and mechanism of tacrolimus on melanogenesis on A375 human melanoma cells. Chin. Med. J. 127, 2966\u20132971 (2014).","journal-title":"Chin. Med. J."},{"key":"2133_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000083516","volume":"210","author":"JC Fricain","year":"2005","unstructured":"Fricain, J. C. et al. Mucosal pigmentation after oral lichen planus treatment with topical tacrolimus. Dermatology 210, 229\u2013232 (2005).","journal-title":"Dermatology"},{"key":"2133_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40272-013-0013-9","volume":"15","author":"WW Carr","year":"2013","unstructured":"Carr, W. W. Topical calcineurin inhibitors for atopic dermatitis: review and treatment recommendations. Paediatr. Drugs 15, 303\u2013310 (2013).","journal-title":"Paediatr. Drugs"},{"key":"2133_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000120676","volume":"18","author":"R Gennuso","year":"1992","unstructured":"Gennuso, R. et al. Lumbar intervertebral disc disease in the pediatric population. Pediatr. Neurosurg. 18, 282\u2013286 (1992).","journal-title":"Pediatr. Neurosurg."},{"key":"2133_CR22","doi-asserted-by":"publisher","first-page":"27S","DOI":"10.1177\/1203475419857668","volume":"23","author":"L Guenther","year":"2019","unstructured":"Guenther, L., Lynde, C. & Poulin, Y. Off-label use of topical calcineurin inhibitors in dermatologic disorders. J. Cutan. Med. Surg. 23, 27S\u201334S (2019).","journal-title":"J. Cutan. Med. Surg."},{"key":"2133_CR23","first-page":"8","volume":"21","author":"E Wong","year":"2016","unstructured":"Wong, E. & Kurian, A. Off-label uses of topical calcineurin inhibitors. Ski. Ther. Lett. 21, 8\u201310 (2016).","journal-title":"Ski. Ther. Lett."},{"key":"2133_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-016-0607-9","volume":"16","author":"EC Siegfried","year":"2016","unstructured":"Siegfried, E. C., Jaworski, J. C., Kaiser, J. D. & Hebert, A. A. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. BMC Pediatr. 16, 75 (2016).","journal-title":"BMC Pediatr."},{"key":"2133_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/phpp.12277","volume":"33","author":"R Li","year":"2017","unstructured":"Li, R. et al. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis. Photodermatol. Photoimmunol. Photomed. 33, 22\u201331 (2017).","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"2133_CR26","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s40261-019-00845-x","volume":"39","author":"W Hu","year":"2019","unstructured":"Hu, W. et al. Efficacy of the topical calcineurin inhibitors tacrolimus and pimecrolimus in the treatment of vitiligo in infants under 2 years of age: a randomized, open-label pilot study. Clin. Drug Investig. 39, 1233\u20131238 (2019).","journal-title":"Clin. Drug Investig."},{"key":"2133_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/srep07408","volume":"4","author":"SJ Lee","year":"2014","unstructured":"Lee, S. J. et al. Functional interpretation of metabolomics data as a new method for predicting long-term side effects: treatment of atopic dermatitis in infants. Sci. Rep. 4, 7408 (2014).","journal-title":"Sci. Rep."},{"key":"2133_CR28","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.1016\/j.jaad.2005.04.062","volume":"53","author":"JM Hanifin","year":"2005","unstructured":"Hanifin, J. M. et al. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. J. Am. Acad. Dermatol. 53, S186\u2013S194 (2005).","journal-title":"J. Am. Acad. Dermatol."},{"key":"2133_CR29","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jaad.2015.02.1116","volume":"72","author":"L Legendre","year":"2015","unstructured":"Legendre, L. et al. Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: a systematic review and meta-analysis. J. Am. Acad. Dermatol. 72, 992\u20131002 (2015).","journal-title":"J. Am. Acad. Dermatol."},{"key":"2133_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1365-2133.2011.10363.x","volume":"165","author":"P Tennis","year":"2011","unstructured":"Tennis, P., Gelfand, J. M. & Rothman, K. J. Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. Br. J. Dermatol. 165, 465\u2013473 (2011).","journal-title":"Br. J. Dermatol."},{"key":"2133_CR31","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamadermatol.2014.4305","volume":"151","author":"DJ Margolis","year":"2015","unstructured":"Margolis, D. J. et al. Association between malignancy and topical use of pimecrolimus. JAMA Dermatol. 151, 594\u2013599 (2015).","journal-title":"JAMA Dermatol."},{"key":"2133_CR32","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1365-2133.2011.10351.x","volume":"165","author":"N Ho","year":"2011","unstructured":"Ho, N. et al. A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0.1% vs. clobetasol propionate 0.05% in childhood vitiligo. Br. J. Dermatol. 165, 626\u2013632 (2011).","journal-title":"Br. J. Dermatol."},{"key":"2133_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1365-4632.2009.03852.x","volume":"48","author":"AE Xu","year":"2009","unstructured":"Xu, A. E. et al. Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo. Int. J. Dermatol. 48, 86\u201390 (2009).","journal-title":"Int. J. Dermatol."},{"key":"2133_CR34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/ced.12742","volume":"41","author":"OJ Park","year":"2016","unstructured":"Park, O. J. et al. A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter. Clin. Exp. Dermatol. 41, 236\u2013241 (2016).","journal-title":"Clin. Exp. Dermatol."},{"key":"2133_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaad.2015.04.008","volume":"73","author":"JM Bae","year":"2015","unstructured":"Bae, J. M. et al. Combination therapy with 308-nm excimer laser, topical tacrolimus, and short-term systemic corticosteroids for segmental vitiligo: a retrospective study of 159 patients. J. Am. Acad. Dermatol. 73, 76\u201382 (2015).","journal-title":"J. Am. Acad. Dermatol."},{"key":"2133_CR36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1365-2230.2004.01632.x","volume":"29","author":"AJ Kanwar","year":"2004","unstructured":"Kanwar, A. J., Dogra, S. & Parsad, D. Topical tacrolimus for treatment of childhood vitiligo in Asians. Clin. Exp. Dermatol. 29, 589\u2013592 (2004).","journal-title":"Clin. Exp. Dermatol."},{"key":"2133_CR37","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/1346-8138.14501","volume":"45","author":"M Ohtsuki","year":"2018","unstructured":"Ohtsuki, M., Morimoto, H. & Nakagawa, H. Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: review on safety and benefits. J. Dermatol. 45, 936\u2013942 (2018).","journal-title":"J. Dermatol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02133-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02133-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02133-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T18:18:30Z","timestamp":1727374710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-022-02133-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["2133"],"URL":"https:\/\/doi.org\/10.1038\/s41390-022-02133-5","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"type":"print","value":"0031-3998"},{"type":"electronic","value":"1530-0447"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"10 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained in all cases, and protocols were approved by the scientific ethical committee of Hospital and registered in Chinese Clinical Trial Registry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}